peptidedosing.eu
Healing & recovery

BPC-157

Talked about for injury recovery, tendons and gut health.

StatusNot approved (EU/UK/US); WADA prohibited
How well studied in peopleSmall human studies
Experts quoted14 experts

iNot medical advice. We don’t recommend any dose. Every dose below is a quote from the person named, describing their views or their own use. BPC-157 is not an approved medicine and is not authorised for human use in the EU.

What experts say about dosing

19 statements from 10 people. Each one is word for word: we add punctuation only and mark cuts with […]. The chips repeat the exact words used.

Dr Luis MartinezPhysician; co-founder of the Clinical Peptide Society

Slides for doctors: 500 mcg a day, capsule or injection

Dose
“500 mcg”
How often
“QD (once a day)”
How taken
“PO (capsules) or SQ”

“BPC 157 | 500 mcg caps PO QD 500 mcg SQ QD | Oral BPC 157 can help heal leaky gut SQ BPC157 is for neuro repair”

Read the source (at p. 30)Peptides for Autoimmune diseases, conference slides by Luis Martinez MD (agemed.org, PDF) · upload date not confirmed

Context: PO QD means by mouth once a day; SQ QD means injected under the skin once a day. The comment is his view, not a trial result. One row of the “Dosing” table (columns Peptide | Dosing | Comments) in his slides for doctors on autoimmune disease; the table cells are separated here by “|”. The slides are undated.

Dr William SeedsOrthopaedic surgeon; founder of the International Peptide Society

Tablets: 500 mcg once or twice a day

Dose
“500 mcg”
How often
“twice a day, even once a day”
How taken
“orally (tablets)”

“The nice thing about BPC, it’s one of the few peptides that you can take orally. They come in 500 mcg tablets. And you can take it twice a day, even once a day. But typically, most of the people use it subQ. But it’s the same effect.”

Read the sourcePeptide Therapy for Anti-Aging, Gut Healing, Tissue Repair & Immune Function (Dr. Ruscio Radio transcript) · 3 Oct 2018

Context: Answering Dr. Michael Ruscio, who asked whether oral or injected BPC-157 is better for problems in different parts of the gut. Just before, Seeds says that taken orally “it works just as well as giving it subQ”; that is his view, not a trial result.

Jay CampbellAuthor and podcaster on hormones and peptides; co-founder of a peptide company

Own use: only for serious injuries

Dose
“200-750 mcg”
How often
“once at morning and once at night”
How long
“a maximum of 12 weeks or until the injury is 100% healed”
How taken
“injected locally at the site of injury, intramuscularly or subcutaneously”

“HOW I USE BPC-157 & TB-500: Only when you or other people get seriously hurt […] 200-750 mcg of BPC-157 injected locally at the site of injury, intramuscularly or subcutaneously, once at morning and once at night. […] Continue this protocol for a maximum of 12 weeks or until the injury is 100% healed”

Read the sourceJay Campbell’s Fully Optimized Peptide Stack For 2022 (jaycampbell.com) · 13 Oct 2022

Context: Own use. The cut lines are his TB-500 dose (shown on the TB-500 page). He describes using BPC-157 and TB-500 “pre-mixed in the same vial” to treat another person’s hand wound.

Vigorous SteveBodybuilding coach and YouTuber (VigorousSteve)

Own use (duration)

Dose
not stated
How long
“four to six weeks in duration”

“I've run a BPC-157 many a time to heal injuries for four to six weeks in duration.”

Watch at 13:14Best Dose Of BPC-157 For Injury Healing & Prevention? (Wolverine Healing Factor) Cancer & Anhedonia? (VigorousSteve, YouTube) · 29 Jan 2024

Context: His own use, not a recommendation. He says this while discussing reported anhedonia, which he says he has not experienced himself. Both caption tracks render the compound name as "BBC 157"; we normalised it to BPC-157.

Soft-tissue injuries (injectable)

Dose
“anywhere between 200 micrograms to 1,000 micrograms”
How long
“let's say, four to six weeks”
How taken
“injected either subcutaneously, intramuscularly, or intra-articularly”
Where
“at least as close to the site of injury as possible”

“So, what is the most effective dose for BPC-157 when it's run solo? Well, for soft tissue injuries, based on all of the scientific evidence that we just reviewed together, a dose anywhere between 200 micrograms to 1,000 micrograms BPC-157 injected either subcutaneously, intramuscularly, or intra-articularly at least as close to the site of injury as possible for a duration of, let's say, four to six weeks.”

Watch at 30:45Best Dose Of BPC-157 For Injury Healing & Prevention? (Wolverine Healing Factor) Cancer & Anhedonia? (VigorousSteve, YouTube) · 29 Jan 2024

Context: The summary at the end of his BPC-157 review. He goes on to say it should ideally be combined with other healing measures (he names thymosin beta-4, growth hormone or secretagogues, GHK-Cu, collagen peptides and vitamin C), and that torn tendons need surgery first: "if you need surgery, get the surgery out of the way first". Earlier in the video he stresses that almost all BPC-157 evidence comes from animal models. The main-channel captions garble "soft tissue" and "site"; the captions of the same audio on his clips channel read as quoted.

Gut problems (oral)

Dose
“anywhere between 250 micrograms to 500 micrograms”
How often
“once or twice per day”
How long
“every single day until the injuries internally within the intestinal tract are resolved”
How taken
“orally”

“If you suffer from […] intestinal injuries, whether that's irritable bowel syndrome or something else, stomach ulcers, for example, then anywhere between 250 micrograms to 500 micrograms orally once or twice per day, so that's a total between 250 micrograms to 1,000 micrograms oral BPC-157 every single day until the injuries internally within the intestinal tract are resolved.”

Watch at 32:01Best Dose Of BPC-157 For Injury Healing & Prevention? (Wolverine Healing Factor) Cancer & Anhedonia? (VigorousSteve, YouTube) · 29 Jan 2024

Context: He adds that it should ideally be combined with LL-37, KPV, glutamine, probiotics and fibre, and that you should follow an elimination diet first to address the root cause. The main-channel captions read "Orly" and "intestinal track"; the clips-channel captions of the same audio read "orally" and "intestinal tract".

Splitting the daily dose

Dose
not stated
How often
“split up your daily dose of BPC-157 into two administrations”

“So based on this data, I would advise you to split up your daily dose of BPC-157 into two administrations”

Watch at 33:44Best Dose Of BPC-157 For Injury Healing & Prevention? (Wolverine Healing Factor) Cancer & Anhedonia? (VigorousSteve, YouTube) · 29 Jan 2024

Context: "This data" is animal pharmacokinetics: he cites an intramuscular half-life of 15 to 30 minutes in animal models, and says the anecdotal figure of 2 to 6 hours "is not confirmed anywhere in the literature". He wants the effects to be continuous.

Andrew HubermanNeuroscientist, Stanford School of Medicine; host of Huberman Lab

Route

Dose
not stated
How taken
“inject it subcutaneously or into the muscle”
Where
“just a few inches off the belly button”
Also said
“direct it to the site of injury by injecting more local”

“By the way, the typical route of taking BPC-157 is either to inject it subcutaneously or into the muscle. And to do that, regardless of where the injury is, they'll do that in one particular site. So subcutaneously, just a few inches off the belly button. […] Or in some cases, people will direct it to the site of injury by injecting more local.”

Watch at 26:22Huberman Lab: Benefits & Risks of Peptide Therapeutics for Physical & Mental Health · 1 Apr 2024 · show notes

Context: He is describing what users report ("anecdata"), not recommending a route. He continues: "we don't know if we're dealing with pure placebo effect or we are dealing with real effects." At 27:37 he adds that the anecdata suggest systemic or local delivery "doesn't seem to matter that much".

Dose, frequency & cycling

Dose
“300 to 500 micrograms”
How often
“maybe two or three times per week”
How long
“a course of about eight weeks”
How taken
“subcutaneously”
Break
“cycle off for anywhere from eight to 10 weeks”

“The typical therapeutic doses that are prescribed are anywhere from 300 to 500 micrograms subcutaneously, maybe two or three times per week. And that is typically done for a course of about eight weeks. And then people typically cycle off for anywhere from eight to 10 weeks. […] I am not suggesting anyone run out and take BPC-157.”

Watch at 29:29Huberman Lab: Benefits & Risks of Peptide Therapeutics for Physical & Mental Health · 1 Apr 2024 · show notes

Context: Descriptive, not a recommendation: he says this right after stressing that a high LD50 in animals "does not mean that anyone should be taking high dosages", calls continuous daily use "a bad idea", and in the omitted part notes some people use it daily without breaks. The final sentence is from 30:01 in the same passage.

Dose, frequency & monitoring

Dose
“about 300 to 500 micrograms”
How often
“two to three times per week, maybe even five days per week”
Also said
“take the minimal effective dose to not just simply do it every day and certainly to not do it continuously”

“BPC-157 is typically taken in these dosages of about 300 to 500 micrograms, you know, two to three times per week, maybe even five days per week. If you're going to go down this path of taking BPC-157, I would encourage you to take the minimal effective dose to not just simply do it every day and certainly to not do it continuously. And of course, to monitor your other health metrics for anything that could potentially resemble cancer or tumor growth”

Watch at 34:30Huberman Lab: Benefits & Risks of Peptide Therapeutics for Physical & Mental Health · 1 Apr 2024 · show notes

Context: Closing summary of his BPC-157 segment, said right after: "the tumor concerns and the lack of human data are a real concern that everyone should be made aware of." Wording follows the official hubermanlab.com transcript; YouTube's auto-captions read "to not simply do it every day" (one-word difference).

Bryan JohnsonEntrepreneur; Blueprint longevity project

Personal protocol

Dose
“0.4mg of per shot”
How often
“1x daily”
How long
“20 days”
How taken
“per injection”
Preparation
“Reconstitute 10mg of BPC-157 in 5ml of BSW solution”

“My BPC-157 protocol: Reconstitute 10mg of BPC-157 in 5ml of BSW solution. Concentration will be 2mg/ml. Administer 0.20ml per injection, which provides 0.4mg of per shot. 1x daily for 20 days.”

Read the sourcePost on X (reply) · 10 Jun 2024

Context: A reply to a follower asking how he used it after his widely shared June 2024 ankle sprain post. It describes his own use only. Two years later he wrote (6 May 2026): "If you don't have the bandwidth for extensive testing, you are better off steering away from unregulated peptides."

Ben GreenfieldFitness and longevity author; host of Ben Greenfield Life

Recovery stack (dosing guidelines)

Dose
“250–350mcg”
How often
“2x/day”
How taken
“Injection”

“Dosing Guidelines: Injection: 250–350mcg 2x/day; OR Injection: 500–700 mcg 1x/day; OR Injection: 0.15mL of 2000mcg/mL solution every day for a 30-day cycle; OR Oral: 500mcg capsules for a 30-day cycle”

Read the sourceBen’s Peptide Stack for Recovery, Explosive Gains, & Ageless Vitality (bengreenfieldlife.com) · 17 Sep 2024

Context: From his “Recover Like Wolverine” stack. He calls these “simply general guidelines”, recommends starting “on the lower end”, and writes that he is not a doctor. He notes WADA has banned BPC-157 since 1 January 2022.

Dr Craig KoniverPhysician; founder of Koniver Wellness (Charleston, US, and London)

With patients: from 500 up to 5,000 mcg a day

Dose
“500 micrograms a day, up to 5,000 micrograms a day”
How often
“five days on, two days off”

“I think, for people understanding using BPC, we started with a dose of 500 micrograms a day. We got up to 5,000 micrograms a day. We'd like a protocol of five days on, two days off.”

Read the sourceDr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity (Huberman Lab transcript) · 7 Oct 2024

Context: Describing what his clinic has used with patients (“we’re talking about thousands upon thousands of patients”). Just before, he says they started “with the dose based upon these, like you said, animal studies, which is conservative” and then went higher. The route is not stated here. Later in the episode he says BPC-157 can no longer be compounded in the US.

Dr Jones DCDoctor of chiropractic (DC); YouTube channel on peptides and GLP-1 medications

Own use: aggressive daily protocol for his shoulder

Dose
“1 milligram of BBC57 […] 2,000 micrograms of TB500”
How often
“every single day”
How long
“three full months”

“I got with my medical team and we decided to run an aggressive Wolverine protocol. 1 milligram of BBC57 or 1,000 micrograms, 2 milligs or 2,000 micrograms of TB500 every single day. Now, what most people don't know, some practitioners are going to work with higher dosing because they understand the severity of the injury and the nature of how much healing it's going to take. And this was a significant injury of mine. Everyone online is talking about 250 or 400 micrograms. That's maintenance or minor stuff. […] I ran this for three full months”

Watch at 6:13Doctor Reacts to Most Powerful Peptide Stacks (GLOW, KLOW & Wolverine) (Dr Jones DC) · 21 Nov 2025

Context: Own use, for a rotator cuff injury that stopped him playing volleyball. “BBC57” is how the captions render BPC-157. He calls this an aggressive protocol for a significant injury.

What he recommends by mouth

Dose
“about 500 micrograms”
How often
“per day”
How taken
“oral”

“I recommend the oral about 500 micrograms per day. The idea here is that oral BBC targets the gut barrier directly as it passes through your digestive system providing that first pass gut contact.”

Watch at 9:58The Hidden Peptide Stack That Doubles Your GLP 1 Results for Autoimmune & Inflammatory Conditions (Dr Jones DC) · 24 Nov 2025

Context: “BBC” is how the captions render BPC. He says just before this that human clinical trials are still limited.

His clinic’s oral protocol (BPC-157 + KPV capsule)

Dose
“500 micrograms”
How often
“one to two times a day”
How long
“3 months on, maybe four at the max, 1 month off”
How taken
“oral capsule”
When
“on an empty stomach”

“So, here it is, the protocol that we actually run. 500 micrograms of BPC-157 combined in a single oral capsule. Now, these are compounded by a licensed 503A pharmacy. You take this on an empty stomach one to two times a day depending on what we're targeting. Cycle duration, 3 months on, maybe four at the max, 1 month off.”

Watch at 6:51BPC-KPV Masterclass How to Use it for MAXIMUM Results (Dr Jones DC) · 4 Oct 2026

Context: The protocol he says his clinic runs. The capsule combines BPC-157 with KPV (a blend); the KPV amount is not stated in this passage.

Nicholas TrigiliHuman performance specialist and coach; fitness YouTuber

Own use: torn pec, years ago

Dose
“one to two maybe 3 milligs … 500 micrograms”
How often
“a day”
How long
“After a month … drop down”
How taken
“injected as close I can to the injury site”

“I said no to the surgery. I took my chance on BPC at one to two maybe 3 milligs a day. Way too much. But nobody knew how to use this stuff properly back then. I injected as close I can to the injury site as I could. […] After a month though, I did drop down to 500 micrograms a day.”

Watch at 3:20If I Started BPC-157 in 2026, I'd Do This (Nicholas Trigili) · 8 Jul 2026

Context: About tearing his pec “almost two decades ago”. The cut removes a sentence on TB-500 whose figures are unclear in the captions (held for a listen) and his recovery timeline. He says in his videos that he is not a doctor.

Own use: loading then maintenance

Dose
“1 mg … 250 to 500 micrograms”
How often
“a day … per day”
How long
“21 to 30 days loading, then maintenance”

“If I haven't used BBC157 in a while, I'm definitely going to start with a loading phase. And the loading phase is usually something very consistent like this, 21 to 30 days on daily, typically 1 mg a day. Yes, that's an aggressive loading phase. […] I will jump right to my maintenance phase, which is anywhere between 250 to 500 micrograms per day.”

Watch at 6:26I’m 39. Here's everything I'm taking to Beat Aging (Full Stack Breakdown) (Nicholas Trigili) · 20 Jul 2026

Context: “BBC157” is how the captions render BPC-157. The cut removes his note that he skips the loading phase if he used it recently. The captions’ “[music]” tag is omitted. He says in his videos that he is not a doctor.

How he runs it now (Sept 2026)

Dose
“500 micrograms”
How often
“a day”
How long
“at least 8 to 12 weeks”
How taken
“subcutaneous as close as possible (injury) … subq in your abdominal wall (gut/systemic)”
Also said
“I start at the low end”

“Here's how I actually structure these two today in my cycles. BPC-157. I run 500 micrograms a day. I start at the low end. I assess how my body responds for the first couple weeks. I look at my digestion. I look at my inflammation. I look at my recovery. And I adjust it from there. So just jumping straight into the high doses like I did that first time around. Not a good idea. If it's for a very specific injury, I'm injecting subcutaneous as close as possible. You can also do inter muscular. It's okay. It's not the end of the world. It's not going to affect anything negatively. If it's for general gut health or the systemic inflammation, subq in your abdominal wall works just as well. The minimal cycle length I suggest is at least 8 to 12 weeks.”

Watch at 5:16I’m 39. Here’s Every Peptide I’ve Run So Far in 2026 (Revealing My Protocols) (Nicholas Trigili) · 24 Sep 2026

Context: Own use. “These two” are BPC-157 and TB-500; “the high doses like I did that first time” refers to his torn-pec use (above). He says all the peptides in this video were taken alongside the testosterone and HGH he runs all year. Caption spelling of the compound name corrected: “BBC57” → BPC-157. He says in his videos that he is not a doctor.

What experts say about safety

12 statements from 8 people about risks and how strong the evidence is.

Derek (More Plates More Dates)Fitness educator; founder of More Plates More Dates

Cancer caution

“I also worry about cancer cell proliferation from something that's pro growing blood vessels. So that is a concern with BPC for sure”

Watch at 3:25:19The Drive podcast #274: Performance-enhancing drugs and hormones (guest: Derek, More Plates More Dates) · 9 Oct 2023

Context: Spoken answer, lightly punctuated. Just before this he says he is "not overly familiar with it to a point that I can say with any certainty" it works for a given condition, and that he has seen "some pretty remarkable improvements" in minor, not complete, tears.

When people use it

“I would probably use it if I had a minor injury to somewhere I needed more blood flow. But I do think a lot of people use it proactively far too often”

Watch at 3:26:26The Drive podcast #274: Performance-enhancing drugs and hormones (guest: Derek, More Plates More Dates) · 9 Oct 2023

Context: He continues that preventive use by athletes is, in his words, "overkill and risky as hell personally", citing its link to VEGF.

Vigorous SteveBodybuilding coach and YouTuber (VigorousSteve)

No human safety studies

“That being said, there are no completed human safety studies of BPC-157 and it appears that it's not entirely side effect free.”

Watch at 9:16Best Dose Of BPC-157 For Injury Healing & Prevention? (Wolverine Healing Factor) Cancer & Anhedonia? (VigorousSteve, YouTube) · 29 Jan 2024

Context: He says that in animal models it appears generally well tolerated. He then lists commonly reported side effects of injections: post-injection pain (mostly burning), sometimes redness at the injection site, and rare anecdotal reports of anhedonia.

Cancer concern

“And extrapolating from the angiogenesis benefit and the wound healing benefits of BPC-157, there could be a potential for cancer progression if cancer is already present in the body.”

Watch at 9:55Best Dose Of BPC-157 For Injury Healing & Prevention? (Wolverine Healing Factor) Cancer & Anhedonia? (VigorousSteve, YouTube) · 29 Jan 2024

Context: Later in the video he calls it "a bit of a double-edged" sword: some animal data suggest protective effects against cancer-induced cachexia, while "there's some speculation in the medical community that BPC-157 treatment might actually accelerate cancer growth".

Andrew HubermanNeuroscientist, Stanford School of Medicine; host of Huberman Lab

Human evidence

“And there are a lot of studies in rats, in mice, and a few other species as well. To my knowledge, there is only one study on humans and it's not a clinical trial. And frankly, it's not the best performed study and that's putting it mildly.”

Watch at 24:58Huberman Lab: Benefits & Risks of Peptide Therapeutics for Physical & Mental Health · 1 Apr 2024 · show notes

Context: Said while describing the BPC-157 literature as starting around 1993 and being overwhelmingly animal-based. He goes on to say that "we actually have essentially no human data" despite widespread use.

Cancer caution

“In other words, BPC-157 is a potential tumor growth risk. So if you have knowledge of a given cancer or you're concerned about tumors at all, I would encourage you to be very cautious about the use of BPC-157.”

Watch at 32:04Huberman Lab: Benefits & Risks of Peptide Therapeutics for Physical & Mental Health · 1 Apr 2024 · show notes

Context: Part of his explanation that BPC-157's reported pro-angiogenic (VEGF) and growth-hormone-receptor effects in animal work could, in theory, also support existing tumours.

Dr Brad StanfieldPrimary-care physician (New Zealand); YouTube educator

Human evidence

“But there's one glaring problem: all of this research so far has been done in animals. To date, there have been no randomized clinical trials on the effects of BPC-157 in humans.”

Watch at 4:39Should You Take BPC-157 Peptides? · 30 Jan 2025

Context: Follows his summary of the rat data (tendon healing, angiogenesis, nitric-oxide signalling). He then critiques the single human knee-pain study as retrospective, uncontrolled and "tiny, just 16 people".

Safety

“There are three strong reasons for caution here. First, we don't know if it's safe. Since there have been no human clinical trials, we don't know whether we're harming ourselves by using the substance.”

Watch at 7:15Should You Take BPC-157 Peptides? · 30 Jan 2025

Context: His other two reasons: product quality is unregulated ("you don't know what you're buying") and BPC-157 is banned for competitive athletes by USADA.

Ben GreenfieldFitness and longevity author; host of Ben Greenfield Life

Cancer & safety

“I'm not going to say that's ironclad and that we don't still have a need for long-term human clinical research on the association between any peptide including BPC 157 and cancer. However, it's very safe, it's very simple and I'm personally comfortable using it.”

Watch at 46:43The Ultimate Peptide Guide: Muscle, Fat Loss & Longevity Secrets (best-of compilation) · 8 Mar 2025

Context: From a listener Q&A clip ("can BPC-157 feed polyp growth in the colon?") included in this compilation; the date shown is the compilation's upload date. Right after this he says that if a colonoscopy found polyps he would restrict anything anabolic, naming BPC-157. This is his personal view, not a clinical finding.

Dr Alex TatemBoard-certified urologist and men’s health specialist; YouTube educator

No established human dose

“That means you need to think carefully about dosing frequency and route. A lot of the protocols floating around online are based off of vibes, not pharmarmacology. The third issue is that there is no established human dose for either compound. Everything is extrapolated from animal studies and alometric scaling from rats to humans is an imprecise science at best.”

Watch at 24:07BPC-157 & TB-500: The Truth About the Wolverine Stack (Dr Alex Tatem) · 5 Mar 2026

Context: “either compound” means BPC-157 and TB-500. “pharmarmacology” and “alometric” are caption spellings.

Bryan JohnsonEntrepreneur; Blueprint longevity project

Unregulated peptides

“If you don't have the bandwidth for extensive testing, you are better off steering away from unregulated peptides. The risk profile of research peptides like BPC-157, TB-500, CJC-1295, and ipamorelin is largely unknown.”

Read the sourcePost on X (reply) · 6 May 2026

Context: Opening of a longer post contrasting grey-market research peptides with approved peptide drugs, whose risk profile is characterised through three trial phases and post-marketing surveillance.

Dr Abud BakriInternal medicine physician; guest on Huberman Lab

The usual dose is not established

“people just go based on the dosage that would fit in the vial […] through a peptide sciences website, rather than what actually-- We don't know what the human dose is- […] for BPC 157. So there's a lot of work to do just to figure that out. When we spoke to the orthopedic group, they're like, "Yeah, we're going to start with 250 micrograms." I'm like, "I don't know if you're going to see an effect at that low of a dose."”

Read the sourceHuberman Lab: Peptides: The Science, Uses & Safety | Dr. Abud Bakri (transcript on hubermanlab.com) · 1 Jun 2026 · Watch the episode on YouTube

Context: He says just before this that he and “some of our people” have used bigger doses after his own tricep tear, without giving an amount.

Go deeper

What the research used

Context, not a dosing guide. These are the conditions reported in published studies, mostly in rats or cells. Animal doses do not translate to people, and none of these studies establishes a safe or effective human dose.

Animal and laboratory studies

StudyStudied inWhat the study usedWhat it found
Staresinic M et al., J Orthop Res 2003;21(6):976-83PubMed 14554208 · DOIRat, surgically transected Achilles tendon10 µg/kg, 10 ng/kg or 10 pg/kg i.p., once daily, first dose 30 min after surgery; assessed up to day 14Better biomechanical, functional and histological healing than saline controls
Chang CH et al., J Appl Physiol 2011;110(3):774-80PubMed 21030672 · DOIRat tendon explants and tendon fibroblasts (ex vivo / in vitro)Concentration-response in cell culture (concentrations in full text)Faster explant outgrowth, better cell survival under oxidative stress, dose-dependent fibroblast migration (FAK-paxillin)
Hsieh MJ et al., J Mol Med 2017;95(3):323-33PubMed 27847966 · DOIRat hind-limb ischaemia; chick CAM assay; human endothelial cellsSee full text (abstract does not state dose)Faster blood-flow recovery and more vessels; VEGFR2 up-regulation and VEGFR2-Akt-eNOS activation. Independent group (Taiwan)
He L et al., Front Pharmacol 2022;13:1026182PubMed 36588717 · DOIRats and beagle dogs (pharmacokinetics)Single IV dose; single IM doses at three ascending levels; repeated IM dosingHalf-life under 30 min; IM bioavailability ~14-19% (rats) and ~45-51% (dogs); broken down to amino acids

Human reports

All three come from the same clinic-based author and none had a control group, so they cannot show whether BPC-157 caused the improvements.

StudyStudied inWhat the study usedWhat it found
Lee E, Padgett B. Altern Ther Health Med 2021;27(4):8-13PubMed 34324435Retrospective chart review, 16 patients with knee pain, no control groupSingle intra-articular injection of BPC-157 (12 patients) or BPC-157 + thymosin β4 (4 patients); amount not given in abstract14 of 16 reported relief at phone follow-up 6-12 months later; self-report only
Lee E, Walker C, Ayadi B. Altern Ther Health Med 2024;30(10):12-17PubMed 39325560Uncontrolled pilot, 12 women with interstitial cystitisInjections totalling 10 mg around the inflamed bladder area during one cystoscopy10 of 12 reported complete symptom resolution; no adverse events reported; no placebo arm
Lee E, Burgess K. Altern Ther Health Med 2025;31(5):20-24PubMed 40131143Safety pilot, 2 adultsIV infusion 10 mg in 250 mL saline over 1 h (day 1), then 20 mg (day 2)No changes in heart, liver, kidney, thyroid or glucose markers; no side effects reported; n = 2

Registered clinical trials

  • NCT02637284: PCO-02 – Safety and Pharmacokinetics Trial. Unknown status; last update Dec 2015; no results posted
  • NCT07437547: BPC 157 for Acute Hamstring Muscle Strain Repair. Recruiting (start Feb 2026)

Reviews

  • Vasireddi N et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J 2025;21(4):485-95. PubMed 40756949 · DOI. 36 studies included: 35 preclinical, 1 clinical. "No clinical safety data were found."
  • McGuire FP et al. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med 2025. PubMed 40789979 · DOI. Narrative review.
What we don’t know yet
  • No published randomised, placebo-controlled human trial.
  • Human pharmacokinetics are unknown; in rats and dogs the half-life was under 30 minutes.
  • Most animal studies come from one research group; independent replication is limited.
  • Pro-angiogenic effects (VEGFR2, eNOS) seen in animals raise a theoretical concern for people with existing tumours.
  • Grey-market products are unregulated, so identity, purity and contamination vary.
Common questions

Has BPC-157 been tested in randomised human trials?

Not as of October 2026. The published human data are a retrospective knee-pain chart review (16 patients), an uncontrolled interstitial-cystitis pilot (12 patients) and a 2-person intravenous safety pilot. One registered hamstring-strain trial (NCT07437547) was recruiting in 2026.

Why does the protocol section only contain quotes?

We do not write our own dose ranges. The protocol cards show, word for word, what named experts have publicly said, with their caveats and a link to the exact moment. Study regimens are listed separately as research context, not as guidance.

Is BPC-157 approved as a medicine?

No. It is not an approved medicine in the EU, UK or US, and it is on the World Anti-Doping Agency prohibited list for athletes.

About this page

Word-for-word statements from well-known health voices about how BPC-157 is dosed, and about its risks, each with their caveats and a timestamped link. The published research is listed separately as context.

Also known as
Body Protection Compound 157, PL 14736, PL-10
Type
Synthetic 15-amino-acid peptide
Last updated
11 Oct 2026

Last reviewed 11 Oct 2026 · Compiled by the Peptide Dosing editorial team · How we check quotes